StockNow
CalendarLog in
Global Markets

EU CHMP recommends Zealand Pharma's (ZEAL DC) Zeydovio for adults with short bowel syndrome

StockNow breaking-news AI analysis

The EU CHMP has recommended Zealand Pharma's Zeydovio for treating adults suffering from short bowel syndrome.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

UKMTO has received a report of an incident in the Strait of Hormuz; The CSO of a vessel has reported a tanker being hit by an unknown projectile causing a fire, which was extinguished

Commodities

Saudis reportedly tells Europe oil refiners that they will get no crude next month

Politics

ECB President Lagarde says rates do not move in lockstep with energy prices, and that other factors play a role